← All trials
NCT05320588
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 25, 2022
- Primary completion
- Apr 30, 2024
- Completion date
- Apr 30, 2027
- First posted
- Apr 11, 2022
- Last posted
- Jul 19, 2022
- Enrollment
- 332
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BiOneCure Therapeutics Inc.Lead sponsor
- BiOneCure Therapeutics Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.